About the symposium
The symposium is held in the first part of September of each year, and is generally attended by 250 – 300 senior investigators, post-docs and graduate students in academia and biotech throughout southern California and beyond. Future scientists have an entire day to interact with national and international experts in the field of biomedical research – an unusual and attractive interaction for their career growth.
This year’s topic is Tumor Dormancy, classically defined as the arrest of tumor growth in the primary site or in metastatic dissemination. Dormancy is a stage in cancer progression where the cells cease dividing but survive in a quiescent state while waiting for appropriate environmental conditions to begin proliferation again.
Course organizers
Sanford Burnham Prebys
UC San Diego
UC San Diego
Salk Institute
Presented by
The Usha Mahajani Committee
Moores Cancer Center at UC San Diego Health
Salk Institute for Biological Studies
Sanford Burnham Prebys
Associate Professor
Fred Hutchinson Cancer Center
Assistant Professor
Department of Cancer and Cellular Biology
Lewis Katz School of Medicine
Fox Chase Cancer Center
President and Scientific Director (interim)
Adjunct Professor in Anatomy and Cell Biology
Montreal Clinical Research Institute (IRCM)
Director and Associate Professor
Cell and Molecular Biology of Cancer Program
NCI-Designated Cancer Center
Cold Spring Harbor Laboratory
Associate Professor
Division of Public Health Sciences
Fred Hutchinson Cancer Center
Herbert and Florence Irving Professor
Director of the Cancer Metastasis Initiative
Herbert Irving Comprehensive Cancer Center
Professor of Genetics and Development
Vagelos College of Physicians and Surgeons
Columbia University
Principal Investigator
Department of Molecular Oncology
H. Lee Moffitt Cancer Center & Research Institute
Medical Oncologist
Assistant Clinical Professor of Medicine
Department of Medicine
UC San Diego